Table 1.
Demographic/Clinical Characteristics of the Sample (N = 276)
| Variables | Number of patients (%) | |
|---|---|---|
| Data collection sitea | Site A | 152 (55.1) |
| Site B | 87 (31.5) | |
| Others | 37 (13.4) | |
| Age (mean years ± SD) | 53.97 (±11.79) | |
| Gender | Female | 228 (82.6) |
| Male | 48 (17.4) | |
| Marital status | Married | 191 (69.2) |
| Single | 81 (29.4) | |
| Missing | 4 (1.4) | |
| Race | Caucasian | 242 (87.7) |
| Non-Caucasian | 30 (10.9) | |
| Missing | 4 (1.4) | |
| Education | High school or less | 70 (25.4) |
| Post-high school education | 201 (72.8) | |
| Missing | 5 (1.8) | |
| Employment status | Employed | 150 (54.3) |
| Unemployed | 122 (44.2) | |
| Missing | 4 (1.5) | |
| Study Groupb | Experimental group | 142 (51.4) |
| Control group | 134 (48.6) | |
| Cancer Type | Breast | 152 (55.1) |
| Lung | 47 (17.0) | |
| Gynaecologic cancer | 32 (11.6) | |
| Lymphoma | 23 (8.3) | |
| Others | 22 (8.0) | |
| Disease stage | Stage 1 | 44 (15.9) |
| Stage 2 | 90 (32.6) | |
| Stage 3 | 68 (24.6) | |
| Stage 4 | 44 (15.9) | |
| Not staged | 30 (10.9) | |
| Time lapse since the first CTX | 43–46 vs. | 159(57.6) |
| 57–60 day | 111(40.2) | |
| Missing | 6 (2.2) | |
| Surgery right before baseline | Yes | 198 (71.7) |
| No | 75 (27.2) | |
| Missing | 3 (1.1) | |
| Treatment modality during the study | CTX only | 250 (90.6) |
| Concurrent treatment with radiation treatment | 18 (6.5) | |
| Missing | 8 (2.9) | |
| Comorbid conditions | Hypertension | 69 (25.0) |
| Arthritis | 28 (10.1) | |
| Hemoglobin at Time 1 | 12.92 (±1.6) | |
| Hemoglobin at Time 2 | 11.75 (±1.6) |
Note.
a
Site A= Fox Chase Cancer Center, Site B= Utah.
b
The primary study was a randomized clinical trial of the effectiveness of a cognitive-behavioral intervention on fatigue and insomnia.